93 related articles for article (PubMed ID: 2864788)
21. [Haloperidol decanoate. Results of an open-ended multicentric study in chronic psychotic states].
Lemperiere T; Ropert R; Leger JM; Alexandre JY; Clerc G; Darondel A; Delaunay J; Delteil P; Malauzat D; Raynaud J
Encephale; 1984; 10(5):217-22. PubMed ID: 6519017
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetic of haloperidol decanoate in psychotic patients (author's transl)].
Parent M; Toussaint C; Driesens F; Gelders Y
Acta Psychiatr Belg; 1981; 81(4):399-406. PubMed ID: 7331843
[No Abstract] [Full Text] [Related]
23. [Quantitative approach to treatment with incisive neuroleptics by therapeutic monitoring].
Balant-Gorgia AE; Eisele R; Garrone G
Schweiz Med Wochenschr; 1985 Jan; 115(1):14-8. PubMed ID: 2857499
[TBL] [Abstract][Full Text] [Related]
24. [Bromperidol decanoate in the residual phase of schizophrenia].
Smeraldi E; Cocconcelli C; Canova L; Faravelli C; Marchetti FP; Mariani G; Rapisarda V
Minerva Psichiatr; 1996 Mar; 37(1):39-44. PubMed ID: 8926856
[TBL] [Abstract][Full Text] [Related]
25. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
Roncoroni D
Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
[TBL] [Abstract][Full Text] [Related]
26. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate.
Gelders YG
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-11. PubMed ID: 3559159
[TBL] [Abstract][Full Text] [Related]
28. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
[TBL] [Abstract][Full Text] [Related]
29. Haloperidol decanoate (Janssen) in the treatment of sexual deviations.
Zbytovský J
Cesk Psychiatr; 1993 Jan; 89(1):15-7. PubMed ID: 8099535
[TBL] [Abstract][Full Text] [Related]
30. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Dencker SJ
J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
[TBL] [Abstract][Full Text] [Related]
31. [Drug treatment of schizophrenic psychoses in puerperium].
Olbrich HM; Martin P
Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
[TBL] [Abstract][Full Text] [Related]
32. [Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses].
Cesková E; Svestka J; Rysánek R
Cesk Psychiatr; 1993 Jan; 89(1):11-4. PubMed ID: 8099534
[TBL] [Abstract][Full Text] [Related]
33. Flupenthixol versus haloperidol in acute psychosis.
Parent M; Toussaint C
Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
[TBL] [Abstract][Full Text] [Related]
34. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
[TBL] [Abstract][Full Text] [Related]
35. Depot neuroleptics for acutely psychotic patients.
Turns DM; Pary R; Tobias CR; James WA
Am J Psychiatry; 1987 Aug; 144(8):1099-100. PubMed ID: 2886066
[No Abstract] [Full Text] [Related]
36. Pharmacology and mechanism of action of existing and new neuroleptics.
Niemegeers CJ
Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):26-36. PubMed ID: 1981439
[No Abstract] [Full Text] [Related]
37. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. An open multicenter study.
Deberdt R; Elens P; Berghmans W; Heykants J; Woestenborghs R; Driesens F; Reyntjens A; van Wijngaarden I
Acta Psychiatr Scand; 1980 Oct; 62(4):356-63. PubMed ID: 7468294
[TBL] [Abstract][Full Text] [Related]
38. 12-month study of haloperidol decanoate in chronic schizophrenic patients.
Gelders YG; Reyntijens AJ; Ash CW; Aerts TJ
Int Pharmacopsychiatry; 1982; 17(4):247-54. PubMed ID: 7185769
[TBL] [Abstract][Full Text] [Related]
39. A six-month follow-up of refractory chronic psychotics treated with Haldol-AID.
Wouters J
Acta Psychiatr Belg; 1978; 78(2):399-406. PubMed ID: 354327
[TBL] [Abstract][Full Text] [Related]
40. [7 years of experience with delayed action neuroleptics].
Noguera Hosta R; Rendueles de Olmedo G
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(3):293-8. PubMed ID: 31066
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]